NeoGenomics Inc (NEO) is a diagnostics & research company listed on US.
Latest reported NEO revenue for 2026-06-30 was $388.3M. Net income was -$14.9M. NEO currently screens at market cap $924.0M.
Use this NEO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NEO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NEO SEC filings page. Lician reads the product cache first so this HTML stays unique to NeoGenomics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full NEO income, balance, and cash tables.